Rx Response To Global HIV Must Be Stronger To Save IP System – Kessler
Executive Summary
Pharmaceutical manufacturers need to do more than rely on President Bush's global AIDS relief initiative if they want to protect the international patent system, former FDA commissioner David Kessler says
You may also be interested in...
PhRMA Prepares For More TRIPS Import Talks; U.S. Lays Out “Interim Plan”
The Pharmaceutical Research & Manufacturers of America expects TRIPS negotiations on the importation of drugs made under compulsory license to resume within several weeks
WTO Patent Declaration Supports Incentives For Rx Companies
The World Trade Organization declaration on pharmaceutical patents includes language encouraging developed countries to provide incentives to industry to improve public health in developing nations
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011